Treatment of benign prostatic hyperplasia is an important and challenging problem of modern medicine. One of the most modern methods of the treatment of this disease is prostatic artery embolization. This procedure is most often done through transfemoral approach. Transradial vascular access has many advantages over the transfemoral access. Our study presents a comparative analysis of the use of transradial and transfemoral approach in this type of interventions. Transradial access was used in 13 patients, and transfemoral access - in 12 patients. The success of the procedure was 100% in both groups. The total duration of the procedure, the time needed for catheterization of internal iliac and prostatic arteries and the radiation exposure were significantly lower in the transradial approach group. There were no significant differences in the incidence of complications between two groups. The use of the transradial access was associated with a significant reduction of the frequency and severity of the discomfort associated with the procedure. Transradial approach has numerous advantages over the transfemoral approach and may have great clinical significance.
Introduction: Even after 2 decades of experience in laparoscopic hepatectomy, data on purely laparoscopic approach for donor hepatectomy in adult living donor liver transplantation (LDLT) is limited, especially from India. We report our series of 10 cases of pure laparoscopic donor hepatectomy from India, which is the largest reported series from the country. Method: We report our initial experience of a purely laparoscopic approach for donor hepatectomy for adult recipients to explore its potential application in the management of donors.We did a retrospective data analysis of 10 consecutive patients operated between Jan 2018 and February 2019. Result: There were 9 right, and 1 left hepatectomy. The median operative time was 486 minutes (range 294-684 minutes), and warm ischemia time was 6 minutes (4-12 minutes). Estimated blood loss was 300 mL (10-850 mL), and none of the patients required intraoperative transfusion. One patient required conversion to Lap Assisted approach, due to biliary anomaly. All patients recovered, and there was no mortality. Conclusion: Purely laparoscopic donor hepatectomy for adult LDLT recipients seems to be a feasible option; with careful patient selection and when performed by experienced surgeons, it may afford results comparable to the open method.
.,5 ель исследования. Провести сравнительный анализ эффективности и без-опасности использования трансрадиального (ТРД) и трансфеморального (ТФД) доступа при эмболизации бронхиальных артерий (ЭБА). Материалы и методы. В исследование вошло 29 пациентов (15 в группу ТРД и 14 в группу ТФД) с массивным или рецидивирующим легочным кровотечением. Ос-новные клинические характеристики пациентов были сопоставимы в обеих группах. Проводилась оценка успеха процедуры, частоты развития осложнений, общей продол-жительности ЭБА, лучевой нагрузки, дискомфорта, связанного с процедурой.Результаты. Успех процедуры составил 100% в обеих группах. Общая продол-жительность процедуры, лучевая нагрузка, частота больших и малых осложнений были сопоставимы между исследуемыми группами. Использование ТРД сопровождалось до-стоверным снижением частоты развития и выраженности дискомфорта, связанного с ЭБА.Выводы. ТРД при проведении ЭБА не уступает в эффективности и безопасно-сти ТФД. Длительность процедуры и лучевая нагрузка сопоставимы при использовании обоих доступов. К преимуществам ТРД относится повышение комфорта пациента по-сле вмешательства.Ключевые слова: легочное кровотечение, эмболизация бронхиальной артерии, трансрадиальный доступ, трансфеморальный доступ.Контактный автор: Хайрутдинов Е.Р.,
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.